retatrutide dosis acaba de cambiar la conversación sobre obesidad. Pero hay letra chica. En el congreso de la Asociación Americana de Diabetes (ADA 2026) se presentó el primer estudio fase 3 de retatrutide Effects of once-weekly subcutaneous retatrutide

The next generation of GLP-1 medications The GLP-1 landscape is evolving rapidly

The fact remains that dual agonism beats single agonism in clinical trials

The benefits of these medications appear to last only as long as you are on them

Studies on mice demonstrated that administration of exendin-4 ( ip ) prior to cognitive tests enhanced performance during difficult probe tests but only in females [50]

Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial

For the calculation, 300 structures were randomly extracted from the first two major clusters of both complexes